Global Trust Asset Management »

Day One Biopharmaceuticals I shares owned by Global Trust Asset Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Global Trust Asset Management from 13F filings

Historical chart of Global Trust Asset Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Global Trust Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Global Trust Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $697 50 13.94
2024-06-30 $689 50 13.78

More positions owned by Global Trust Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Ishares Tr Core S&p Scp Etf (IJR)
Nextera Energy (NEE)
Ishares Tr Core Msci Eafe (IEFA)
Lowe's Companies (LOW)
Mastercard Incorporated Cl A (MA)
Caterpillar (CAT)
Amazon (AMZN)

View all positions for Global Trust Asset Management

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
BlackRock
Franklin Resources
Braidwell
Deerfield Management Company
State Street Corporation
Estuary Capital Management
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Henderson Group
TimesSquare Capital Management
Geode Capital Management

View all funds holding Day One Biopharmaceuticals I